BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18048991)

  • 1. Divided-dose administration of miglitol just before and 15 minutes after the start of a meal smoothes postprandial plasma glucose excursions and serum insulin responses in healthy men.
    Aoki K; Kato H; Terauchi Y
    Endocr J; 2007 Dec; 54(6):1009-14. PubMed ID: 18048991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of efficacy and safety of taking miglitol dissolved in water during a meal and taking a miglitol tablet just before a meal in patients with type 2 diabetes.
    Shibata E; Aoki K; Tajima K; Taguri M; Terauchi Y
    Expert Opin Pharmacother; 2016; 17(7):889-94. PubMed ID: 26918556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pre-meal versus post-meal administration of miglitol on plasma glucagon-like peptide-1 and glucosedependent insulinotropic polypeptide levels in healthy men.
    Aoki K; Miyazaki T; Nagakura J; Orime K; Togashi Y; Terauchi Y
    Endocr J; 2010; 57(8):673-7. PubMed ID: 20519807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of miglitol until 30 min after the start of a meal is effective in type 2 diabetic patients.
    Aoki K; Nakamura A; Ito S; Nezu U; Iwasaki T; Takahashi M; Kimura M; Terauchi Y
    Diabetes Res Clin Pract; 2007 Oct; 78(1):30-3. PubMed ID: 17493703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of miglitol as an add-on to bolus insulin on postprandial glycemic excursions in type 2 diabetes patients assessed by continuous glucose monitoring.
    Matsuura K; Mori Y; Nakamura A; Yokoyama J; Utsunomiya K
    Diabetes Technol Ther; 2012 May; 14(5):423-9. PubMed ID: 22316114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using miglitol at 30 min before meal is effective in hyperinsulinemic hypoglycemia after a total gastrectomy.
    Shirakawa J; Murohashi Y; Okazaki N; Yamazaki S; Tamura T; Okuyama T; Togashi Y; Terauchi Y
    Endocr J; 2014; 61(11):1115-23. PubMed ID: 25142087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Miglitol administered before breakfast increased plasma active glucagon-like peptide-1 (GLP-1) levels after lunch in patients with type 2 diabetes treated with sitagliptin.
    Aoki K; Kamiyama H; Yoshimura K; Shibuya M; Masuda K; Terauchi Y
    Acta Diabetol; 2012 Jun; 49(3):225-30. PubMed ID: 21898126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of postprandial blood glucose by the alpha-glucosidase inhibitor Miglitol (BAY m 1099) in type II diabetes.
    Heinz G; Komjati M; Korn A; Waldhäusl W
    Eur J Clin Pharmacol; 1989; 37(1):33-6. PubMed ID: 2687007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of miglitol, sitagliptin or their combination on plasma glucose, insulin and incretin levels in non-diabetic men.
    Aoki K; Masuda K; Miyazaki T; Togashi Y; Terauchi Y
    Endocr J; 2010; 57(8):667-72. PubMed ID: 20519806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of miglitol administration to non-insulin-dependent diabetic rats.
    Tormo MA; Ropero MF; Nieto M; Martinez IM; Campillo JE
    Gen Pharmacol; 1998 Jan; 30(1):125-9. PubMed ID: 9457493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose tolerance and insulin resistance in the JCR:LA-corpulent rat: effect of miglitol (Bay m1099).
    Russell JC; Graham SE; Dolphin PJ
    Metabolism; 1999 Jun; 48(6):701-6. PubMed ID: 10381143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 3-month repeated administration of miglitol on vascular endothelial function in patients with diabetes mellitus and coronary artery disease.
    Emoto T; Sawada T; Hashimoto M; Kageyama H; Terashita D; Mizoguchi T; Mizuguchi T; Motodi Y; Iwasaki M; Taira K; Okamoto H; Matsuo Y; Kim SK; Takarada A; Yokoyama M
    Am J Cardiol; 2012 Jan; 109(1):42-6. PubMed ID: 21944671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Miglitol (Bay m1099), a new alpha-glucosidase inhibitor, on glucose, insulin, C-peptide and GIP responses to an oral sucrose load in patients with post-prandial hypoglycaemic symptoms.
    Renard E; Parer-Richard C; Richard JL; Jureidini S; Orsetti A; Mirouze J
    Diabete Metab; 1991; 17(3):355-62. PubMed ID: 1884880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of miglitol, vildagliptin, or their combination on serum insulin and peptide YY levels and plasma glucose, cholecystokinin, ghrelin, and obestatin levels.
    Aoki K; Kamiyama H; Masuda K; Kamiko K; Noguchi Y; Tajima K; Terauchi Y
    Endocr J; 2014; 61(3):249-56. PubMed ID: 24389993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Miglitol: a review of its therapeutic potential in type 2 diabetes mellitus.
    Scott LJ; Spencer CM
    Drugs; 2000 Mar; 59(3):521-49. PubMed ID: 10776834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic treatment of African-American type 2 diabetic patients with alpha-glucosidase inhibition.
    Johnston PS; Feig PU; Coniff RF; Krol A; Kelley DE; Mooradian AD
    Diabetes Care; 1998 Mar; 21(3):416-22. PubMed ID: 9540025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Miglitol suppresses the postprandial increase in interleukin 6 and enhances active glucagon-like peptide 1 secretion in viscerally obese subjects.
    Arakawa M; Ebato C; Mita T; Fujitani Y; Shimizu T; Watada H; Kawamori R; Hirose T
    Metabolism; 2008 Sep; 57(9):1299-306. PubMed ID: 18702958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of pre- vs. postmeal administration of miglitol for 3 months in type 2 diabetic patients.
    Aoki K; Nakajima S; Nezu U; Shinoda K; Terauchi Y
    Diabetes Obes Metab; 2008 Sep; 10(10):970-2. PubMed ID: 18721256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Miglitol (Bay m 1099) has no extraintestinal effects on glucose control in healthy volunteers.
    Sels JP; Nauta JJ; Menheere PP; Wolffenbuttel BH; Nieuwenhuijzen Kruseman AC
    Br J Clin Pharmacol; 1996 Oct; 42(4):503-6. PubMed ID: 8904624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does suppression of postprandial blood glucose excursions by the alpha-glucosidase inhibitor miglitol improve insulin sensitivity in diet-treated type II diabetic patients?
    Johnson AB; Taylor R
    Diabetes Care; 1996 Jun; 19(6):559-63. PubMed ID: 8725851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.